Delivery Order SPE2DB22D1017-SPE2DB23FG3PX
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $3,071.57 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4562259384 Nitrofurantoin Mono-MCR 100 mg tablets, 100 per bottle. The contract has a completion date of September 11, 2023 and was awarded on September 8, 2023. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,962.11 firm fixed-price delivery order is for the supply of 4,566,995,841 units of NITROFURANTOIN MONO-MCR 100 MG 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,106.37, is for the delivery of 4567670792 NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 25, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
- The federal contract award is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 6, 2025 with a ceiling value of $4,017.66. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, and has an ultimate completion date of June 9, 2025. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,960,849 units of the pharmaceutical product Nitrofurantoin Mono-MCR 100 MG. The $1,531.01 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal...
- This federal contract award is for the delivery of 4,565,851,510 units of the pharmaceutical product NITROFURANTOIN MONO-MCR 100 MG 100S. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,547.65 and is a Firm Fixed Price Delivery Order with a completion date of September 19, 2024. The contract is not set aside for any special designation. AmerisourceBergen...
- This federal contract award is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S medication to the Defense Logistics Agency (DLA). The contract, valued at $5,276.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on October 27, 2022 with an ultimate completion date of October 30, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,492.31 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of November 21, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $5,101.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of May 14, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. There was no set-aside designation associated with this award....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of NITROFURANTOIN MONO-MCR 100 MG 1000S. The contract has a ceiling value of $14,522.98 and is a Firm Fixed Price Delivery Order contract that runs through November 24, 2023. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FG3PXDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,116.35 for the supply of 4,562,252 units of NITROFURANTOIN MONO-MCR 100 MG. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 21, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is part of that larger IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 9/20/23 |